IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
FEDERAL LOBBYING RECORDS

LOBBYING FILINGS AND MARKET CONTEXT

Indexed federal lobbying filings mapped to clients, registrants, and public-company tickers. Transaction dates are compared with filing periods to identify date-proximity review flags. Proximity does not establish coordination, influence, or wrongdoing.

Filings tracked
20,641
thru 2026-07-15
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,260
paying companies
Tickers targeted
1,219
public companies

Clients by reported amount

Mapped tickers by reported amount

#TickerFilingsTotal $
1META
Meta Platforms Inc.
134$50.3M
2PFE
Pfizer Inc.
89$48.7M
3GM
General Motors Company
103$48.4M
4V
Visa Inc.
47$37.7M
5AMZN
Amazon.com Inc.
82$35.4M
6LMT
Lockheed Martin Corporation
92$29.5M
7FDX
FedEx Corporation
83$28.4M
8LLY
Eli Lilly and Company
88$28.4M
9AMGN
Amgen Inc.
100$28.0M
10MRK
Merck & Co. Inc.
92$27.5M
11AAPL
Apple Inc.
66$27.0M
12GOOGL
Alphabet Inc. Class A
128$26.8M
13MO172$26.4M
14SO
Southern Company
110$26.2M
15UNH
UnitedHealth Group Inc.
68$24.0M
16VZ
Verizon Communications Inc.
119$23.8M
17TMUS170$22.9M
18CHTR142$22.8M
19GD
General Dynamics Corporation
131$22.6M
20T
AT&T Inc.
137$21.7M
21ORCL
Oracle Corporation
135$20.8M
22CMCSA
Comcast Corporation
142$20.5M
23OXY
Occidental Petroleum Corporation
38$20.1M
24CI
The Cigna Group
64$19.9M
25MSFT
Microsoft Corporation
126$19.3M

🆕 Filtered Filings · SONOSITE A SUBSIDIARY OF FUJIFILM (FORMERLY SONOSITE INC.)

clear filters
DateTickerClientRegistrantAmountIssue
2025-07-21SONOSONOSITE A SUBSIDIARY OF FUJIFILM (FORMERLY SONOSITE INC.)GALILEO CONSULTING GROUP, INC.$0Preserve Medicare reimbursement for ultrasound services. Promoting ultrasound services with policymakers as a way to save the Medicare program money and increase patient safety. H.R.1 - One Big Beautiful Bill Act 119th Congress (2025-2026), 07/04/2025 Became Public Law No: 119-21. Medicare pricing transparency and site-neutral payments, ensuring year-end legislation does not contain as a pay-for.
2025-04-21SONOSONOSITE A SUBSIDIARY OF FUJIFILM (FORMERLY SONOSITE INC.)GALILEO CONSULTING GROUP, INC.$0Preserve Medicare reimbursement for ultrasound services. Promoting ultrasound services with policymakers as a way to save the Medicare program money and increase patient safety. Medicare pricing transparency and site-neutral payments, ensuring year-end legislation does not contain as a pay-for. FY2025 Full-Year Continuing Appropriations and Extensions Act (through 9/30/2025) H.R. 1968 P.L. 119-4 (03/15/2025). FY 2025 Federal Funding for the ALT-ED Program at SAMSHA, continued implementation of program for FY 2024, FY2025 Full-Year Continuing Appropriations and Extensions Act (through 9/30/2025) H.R. 1968 P.L. 119-4 (03/15/2025).
2025-01-19SONOSONOSITE A SUBSIDIARY OF FUJIFILM (FORMERLY SONOSITE INC.)GALILEO CONSULTING GROUP, INC.$30KPreserve Medicare reimbursement for ultrasound services. Promoting ultrasound services with policymakers as a way to save the Medicare program money and increase patient safety; Medicare pricing transparency and site-neutral payments, ensuring year-end legislation does not contain as a pay-for, FY2025 Continuing Resolution and Other Matters Act (through 3/28/2025) H.R. 9494 and FY2025 Further Continuing Appropriations Act (through 3/14/2025) H.R. 10545. Continued funding for FY 2025 for healthcare services and healthcare infrastructure at VA medical centers, FY2025 Continuing Resolution and Other Matters Act (through 3/28/2025) H.R. 9494 and FY2025 Further Continuing Appropriations Act (through 3/14/2025) H.R. 10545. FY 2025 Federal Funding for the ALT-ED Program at SAMSHA, continued implementation of program for FY 2024. Patient Safety and policies that promote or expand the knowledge and use of patient safety protocols that include the use of ultrasound guidance.